BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heidari P, Kunawudhi A, Martinez-Quintanilla J, Szretter A, Shah K, Mahmood U. Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions. Theranostics 2018;8:3380-91. [PMID: 29930736 DOI: 10.7150/thno.24017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Siafaka PI, Okur ME, Erim PD, Çağlar EŞ, Özgenç E, Gündoğdu E, Köprülü REP, Karantas ID, Üstündağ Okur N. Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today? Pharmaceutics 2022;14:2425. [DOI: 10.3390/pharmaceutics14112425] [Reference Citation Analysis]
2 Kotzerke J, Buesser D, Naumann A, Runge R, Huebinger L, Kliewer A, Freudenberg R, Brogsitter C. Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy. Cancers 2022;14:2513. [DOI: 10.3390/cancers14102513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li X, Yang X, Li Z, Zheng X, Peng YJ, Lin W, Zhou L, Cao D, Situ M, Tu Q, Huang H, Fan W, Feng G, Zhang X. Development of a Radiotracer for PET Imaging of the SNAP Tag. ACS Omega 2022;7:7550-5. [PMID: 35284707 DOI: 10.1021/acsomega.1c05856] [Reference Citation Analysis]
4 Wang F, Chen S, Zheng H, Guo B. Design of an Intron-Retained Bioluminescence Reporter and its Application in Imaging of Pre-mRNA Splicing in Living Subjects. Bioluminescence 2022. [DOI: 10.1007/978-1-0716-2453-1_16] [Reference Citation Analysis]
5 Barca C, Griessinger CM, Faust A, Depke D, Essler M, Windhorst AD, Devoogdt N, Brindle KM, Schäfers M, Zinnhardt B, Jacobs AH. Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy. Pharmaceuticals (Basel) 2021;15:13. [PMID: 35056071 DOI: 10.3390/ph15010013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Nethi SK, Bhatnagar S, Prabha S. Synthetic Receptor-Based Targeting Strategies to Improve Tumor Drug Delivery. AAPS PharmSciTech 2021;22:93. [PMID: 33683499 DOI: 10.1208/s12249-021-01919-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Jacobs AH, Schelhaas S, Viel T, Waerzeggers Y, Winkeler A, Zinnhardt B, Gelovani J. Imaging of Gene and Cell-Based Therapies: Basis and Clinical Trials. Molecular Imaging 2021. [DOI: 10.1016/b978-0-12-816386-3.00060-0] [Reference Citation Analysis]
8 Li X, Yin G, Ji W, Liu J, Zhang Y, Wang J, Zhu X, Zhu L, Dai D, Ma W, Xu W. 18F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model. Onco Targets Ther 2020;13:11659-68. [PMID: 33223839 DOI: 10.2147/OTT.S271657] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Kim YI, Yoo C, Oh SJ, Lee SJ, Kang J, Hwang HS, Hong SM, Ryoo BY, Ryu JS. Tumour-to-liver ratio determined by [68Ga]Ga-DOTA-TOC PET/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours. EJNMMI Res 2020;10:63. [PMID: 32542576 DOI: 10.1186/s13550-020-00651-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
10 Kilian K, Cheda Ł, Sitarz M, Szkliniarz K, Choiński J, Stolarz A. Separation of 44Sc from Natural Calcium Carbonate Targets for Synthesis of 44Sc-DOTATATE. Molecules 2018;23:E1787. [PMID: 30036947 DOI: 10.3390/molecules23071787] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]